Top Markets
#1 Akedo Akedo +128.53%
#2 TENDIES TENDIES +95.14%
#3 Threshold Network Threshold Network +43.87%
#4 Verus Coin Verus Coin +43.84%
#5 Mubarak Mubarak +28.64%
#6 Bitway Bitway +24.60%
#7 Palladium Network Palladium Network +22.70%
#8 Cash Cat Cash Cat +21.77%
#9 MultiversX MultiversX +18.70%
#10 Wrapped Aave Ethereum USDC Wrapped Aave Ethereum USDC +18.00%
Coin of the day
Akedo Akedo
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Regulus Therapeutics Inc. Regulus Therapeutics Inc.

Regulus Therapeutics Inc.

RGLS
Hisse Senetlerindeki Sıralama #17600
Regulus Therapeutics Inc., a biopharmaceutical firm in its clinical development... Regulus Therapeutics Inc., a biopharmaceutical firm in its clinical development phase, is dedicated to uncovering and advancing novel medications. Based in San Diego, California, the company's core focus is on modulating microRNAs to combat a variety of diseases across the United States. Its current pipeline highlights RG-012, an anti-miR compound engineered to inhibit miR-21, which is currently in a Phase II clinical study for Alport syndrome, a severe renal condition. Another significant candidate, RGLS8429, an anti-miR agent targeting miR-17, is being evaluated in a Phase 1b clinical trial for autosomal dominant polycystic kidney disease. Beyond these clinical programs, Regulus is also cultivating an extensive preclinical portfolio, emphasizing drug candidates with precise, organ-selective delivery strategies. The company was established in 2007.
Hisse Fiyatı
$8.16
Son senkronizasyon: 2025-06-26
Piyasa Değeri
$234.57M
Değişim (1 gün)
0.00%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret Regulus Therapeutics Inc. (RGLS)

Kategori

Healthcare
Regulus Therapeutics Inc. (RGLS) için P/S oranı
September 2026 itibarıyla P/S oranı TTM: 0.00
Regulus Therapeutics Inc. şirketinin en son mali raporları ve hisse fiyatına göre, mevcut P/S oranı (TTM) 0.00'dir. 2023 yılının sonunda şirketin P/S oranı 0.00 idi.
Regulus Therapeutics Inc. için P/S oranı geçmişi 2010 - 2026 arası
Her yılın sonunda P/S oranı
Yıl P/S Oranı Değiştir
2026 (TTM) 0.00 0.00%
2024 0.00 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 -100.00%
2020 4.72 109.88%
2019 2.25 -98.00%
2018 112.61 -92.50%
2017 1.50K 1,409.28%
2016 99.52 360.84%
2015 21.60 -76.58%
2014 92.22 534.60%
2013 14.53 256.69%
2012 4.07 5,109.59%
2011 0.08 -37.59%
2010 0.13 0.00%
Benzer şirketler veya rakipler için P/S oranı
Şirket P/S Oranı P/S Oranı Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.95 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
12.19 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
24.99 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.75 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH